Here, we used the US Department of Veterans Affairs databases to build a cohort of people with diabetes who initiated GLP-1RA ( n = 215,970) and compared them to those who initiated sulfonylureas ( n = 159,465), dipeptidyl peptidase 4 (DPP4) inhibitors ( n = 117,989) or sodiumglucose cotransporter-2 (SGLT2) inhibitors ( n = 258,614), a control group composed of an equal proportion of individuals initiating sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors ( n = 536,068), and a control group of 1,203,097 individuals who continued use of non-GLP-1RA antihyperglycemics (usual care)
This study was a randomized, double-blinded, placebo-controlled, crossover clinical investigation that aimed to evaluate the impact of MC4R agonism on sexual brain processing
The duration that a B12 injection remains effective in your body depends primarily on which formulation you receive
Brand name(s) for weight loss: Wegovy is currently the only brand name version of semaglutide that is FDA-approved for weight loss and management
BelleHealth is our telehealth division, focusing on cutting-edge GLP-1 treatments designed to help individuals manage weight and improve overall health through personalized medical care